What is Xerox Holdings Corporation's earnings per share (EPS)?

Xerox Holdings Corporation (XRX) reported diluted earnings per share of -$8.25 for fiscal year 2025. This represents a 23.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Xerox Holdings Corporation (XRX) Financials

XRX

Trailing 12 months to June 30, 2026

Revenue $7.8B +25.6% YoY

Net Income -$925.0M +35.0% YoY

EPS (Diluted) -$7.36 +36.2% YoY

Free Cash Flow $163.0M -52.8% YoY

Market Cap $372.9M as of Oct 13, 2026

Price / Sales 0.0x on $7.8B revenue, trailing 12 months to June 30, 2026

Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to June 30, 2026

Price / Book 1.2x on $323.0M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 13, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 6, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the XRX SEC filings page.

Xerox Holdings Corporation (XRX) reported $7.8B in revenue over the twelve months to Jun 30, 2026, up 25.6% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 9 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI XRX FY2025 2026-10-03

Revenue recovered in FY2025, but shrinking equity and rising leverage left the business less financially flexible.

Cash conversion diverged from accounting results: FY2025 produced operating cash flow of $224M despite a net loss of $1.03B. Free cash flow was $187M, just $37M below operating cash flow, so capital spending was not the main drag; the gap instead points to noncash accounting items and working-capital effects.

The balance sheet became structurally more leveraged: total liabilities reached $9.2B in FY2025 while equity was only $444M, leaving little balance-sheet cushion relative to obligations. Debt-to-equity rose to 9.0x from 2.6x in FY2024, indicating that leverage—not merely annual profitability—now shapes the company's financial position.

Top-line recovery did not restore profitability: revenue rebounded to $7.0B from $6.2B in FY2024. FY2025 still carried a net margin of -14.7%, showing that higher sales were not yet translating into bottom-line earnings.

Financial Health Signals

Financial Health Score 19/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Xerox Holdings Corporation's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Not available for Xerox Holdings Corporation, and counted as zero in the overall score.

Growth

Xerox Holdings Corporation's revenue grew 12.9% year-over-year to $7.0B, a solid pace of expansion. This earns a growth score of 34/100.

Leverage

Xerox Holdings Corporation has elevated debt relative to equity (D/E of 9.04), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 6/100, reflecting increased financial risk.

Liquidity

Xerox Holdings Corporation's current ratio of 1.11 is below the typical benchmark, resulting in a score of 24/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow

Xerox Holdings Corporation has a free cash flow margin of 2.7%, earning a moderate score of 48/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Not available for Xerox Holdings Corporation, and counted as zero in the overall score.

Piotroski F-Score Partial

3/8

Xerox Holdings Corporation passes 3 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.

Earnings Quality Mixed

N/A

Xerox Holdings Corporation reported a net loss of $1.0B while generating $224.0M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$1.9B

YoY+22.0%

QoQ+4.1%

5Y CAGR+1.4%

Xerox Holdings Corporation generated $1.9B in revenue in Q2 2026. This represents an increase of 22.0% from the same quarter a year earlier. Against the prior quarter it is up 4.1%.

Net Income

$13.0M

YoY+112.3%

QoQ+112.4%

Xerox Holdings Corporation reported $13.0M in net income in Q2 2026. This represents an increase of 112.3% from the same quarter a year earlier. Against the prior quarter it is up 112.4%.

EPS (Diluted)

$0.07

QoQ+108.3%

5Y CAGR-31.4%

Xerox Holdings Corporation earned $0.07 per diluted share (EPS) in Q2 2026. Against the prior quarter it is up 108.3%.

EBITDA

Not reported for Q2 2026.

Cash & Balance Sheet

Free Cash Flow

$23.0M

YoY+253.3%

QoQ+114.7%

5Y CAGR-35.7%

Xerox Holdings Corporation generated $23.0M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 253.3% from the same quarter a year earlier. Against the prior quarter it is up 114.7%.

Cash & Debt

$495.0M

YoY+10.2%

QoQ-15.4%

5Y CAGR-25.3%

Xerox Holdings Corporation held $495.0M in cash against $4.2B in long-term debt as of Q2 2026.

Dividends Per Share

$0.03

QoQ0.0%

5Y CAGR-36.9%

Xerox Holdings Corporation paid $0.03 per share in dividends in Q2 2026. It is unchanged from the prior quarter.

Shares Outstanding

131M

QoQ+0.4%

5Y CAGR-6.0%

Xerox Holdings Corporation had 131M shares outstanding in Q2 2026. Against the prior quarter it is up 0.4%.

Margins & Returns

Gross Margin

10.6%

YoY+6.8pp

QoQ+6.7pp

Xerox Holdings Corporation's gross margin was 10.6% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 6.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 6.7 percentage points.

Net Margin

0.7%

YoY+7.4pp

QoQ+6.4pp

Xerox Holdings Corporation's net profit margin was 0.7% in Q2 2026, showing the share of revenue converted to profit. This is up 7.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 6.4 percentage points.

Return on Equity

4.0%

YoY+13.5pp

QoQ+39.1pp

Xerox Holdings Corporation's ROE was 4.0% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 13.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 39.1 percentage points.

Operating Margin

Not reported for Q2 2026.

Capital Allocation

Capital Expenditures

$14.0M

YoY+250.0%

QoQ+16.7%

5Y CAGR+28.5%

Xerox Holdings Corporation invested $14.0M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 250.0% from the same quarter a year earlier. Against the prior quarter it is up 16.7%.

R&D Spending

Not reported for Q2 2026.

Share Buybacks

Not reported for Q2 2026.

XRX Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

XRX quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K
Revenue	$7.8B	$7.0B+12.9%	$6.2B-9.7%	$6.9B-3.1%	$7.1B+1.0%	$7.0B+0.2%	$7.0B-22.5%	$9.1B-6.2%	$9.7B-3.3%	$10.0B
Gross Profit	N/A	N/A	N/A	N/A	$275.0M-26.7%	$375.0M	N/A	N/A	N/A	N/A
SG&A Expenses	$1.8B	$1.7B+7.6%	$1.5B-9.4%	$1.7B-3.6%	$1.8B+2.4%	$1.7B-7.2%	$1.9B-11.2%	$2.1B-12.4%	$2.4B-5.4%	$2.5B
Interest Expense	$422.0M	$334.0M+48.4%	$225.0M+13.6%	$198.0M-0.5%	$199.0M-3.9%	$207.0M-3.7%	$215.0M-8.9%	$236.0M-3.3%	$244.0M-3.2%	$252.0M
Income Tax	$522.0M	$541.0M+415.2%	$105.0M+462.1%	-$29.0M-866.7%	-$3.0M+82.4%	-$17.0M-126.6%	$64.0M-64.2%	$179.0M-27.5%	$247.0M-47.2%	$468.0M
Net Income	-$925.0M	-$1.0B+22.1%	-$1.3B-132200.0%	$1.0M+100.3%	-$322.0M+29.2%	-$455.0M-337.0%	$192.0M-85.8%	$1.4B+274.8%	$361.0M+85.1%	$195.0M
EPS (Basic)	N/A	-$8.25+23.3%	-$10.75-11844.4%	-$0.09+95.8%	-$2.15+16.0%	-$2.56-401.2%	$0.85-85.9%	$6.03+330.7%	$1.40+97.2%	$0.71
EPS (Diluted)	-$7.36	-$8.25+23.3%	-$10.75-11844.4%	-$0.09+95.8%	-$2.15+16.0%	-$2.56-404.8%	$0.84-85.5%	$5.80+320.3%	$1.38+94.4%	$0.71
Diluted Shares (Avg)	N/A	N/A	N/A	N/A	N/A	183M-12.4%	209M-5.9%	222M-11.8%	252M-1.9%	257M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$1.9B+22.0%	$1.8B+26.7%	$2.0B+25.7%	$2.0B+28.3%	$1.6B-0.1%	$1.5B-3.0%	$1.6B-8.6%	$1.5B-7.5%
Gross Profit	$203.0M+244.1%	$72.0M+227.3%	N/A	N/A	$59.0M	$22.0M	N/A	N/A
SG&A Expenses	$432.0M+17.4%	$430.0M+13.8%	$431.0M+14.3%	$477.0M+28.9%	$368.0M-6.4%	$378.0M-4.8%	$377.0M-14.3%	$370.0M-11.1%
Interest Expense	$118.0M+51.3%	$103.0M+87.3%	$100.0M+81.8%	$101.0M+77.2%	$78.0M+30.0%	$55.0M+3.8%	$55.0M-5.2%	$57.0M+29.5%
Income Tax	$18.0M-60.9%	$32.0M+39.1%	$12.0M-29.4%	$460.0M+289.8%	$46.0M+557.1%	$23.0M+162.2%	$17.0M+156.7%	$118.0M+686.7%
Net Income	$13.0M+112.3%	-$105.0M-16.7%	-$73.0M-247.6%	-$760.0M+36.9%	-$106.0M-688.9%	-$90.0M+20.4%	-$21.0M+63.8%	-$1.2B-2559.2%
EPS (Basic)	$0.07+108.0%	-$0.84-12.0%	-$0.58-190.0%	-$6.01+38.1%	-$0.87-825.0%	-$0.75+20.2%	-$0.20+50.0%	-$9.71-3448.3%
EPS (Diluted)	$0.07	-$0.84-12.0%	-$0.58-190.0%	-$6.01+38.1%	-$0.87-890.9%	-$0.75+20.2%	-$0.20+48.7%	-$9.71-3567.9%
Diluted Shares (Avg)	N/A	N/A	N/A	127M+2.1%	126M+1.3%	125M+1.0%	N/A	124M-20.9%

Not reported in any period shown, so not listed: Cost of Revenue, R&D Expenses, Operating Income, EBITDA.

XRX Balance Sheet

XRX quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K
Total Assets	$9.8B+17.4%	$8.4B-16.4%	$10.0B-13.3%	$11.5B-12.7%	$13.2B-10.3%	$14.7B-2.0%	$15.0B+1.2%	$14.9B	N/A
Current Assets	$3.6B+21.6%	$2.9B-7.6%	$3.2B-22.6%	$4.1B-12.6%	$4.7B-18.7%	$5.8B-5.8%	$6.1B+30.3%	$4.7B	N/A
Cash & Equivalents	$512.0M-11.1%	$576.0M+11.0%	$519.0M-50.3%	$1.0B-43.2%	$1.8B-29.9%	$2.6B-4.2%	$2.7B+153.5%	$1.1B-21.0%	$1.4B
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$1.0B+46.2%	$695.0M+5.1%	$661.0M-17.1%	$797.0M+14.5%	$696.0M-17.4%	$843.0M+21.5%	$694.0M-16.3%	$829.0M	N/A
Accounts Receivable	$1.1B+41.0%	$796.0M-6.4%	$850.0M-0.8%	$857.0M+4.8%	$818.0M-7.4%	$883.0M-28.6%	$1.2B-2.7%	$1.3B	N/A
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$2.2B+14.7%	$1.9B-29.5%	$2.7B-2.6%	$2.8B-14.2%	$3.3B-19.3%	$4.1B+4.4%	$3.9B+1.1%	$3.9B-1.6%	$3.9B
Total Liabilities	$9.2B+29.6%	$7.1B-2.4%	$7.2B-9.2%	$8.0B-6.9%	$8.6B-4.2%	$8.9B-3.3%	$9.2B-4.0%	$9.6B	N/A
Current Liabilities	$3.2B+23.0%	$2.6B-5.8%	$2.8B-16.5%	$3.3B+17.7%	$2.8B+14.2%	$2.5B-27.9%	$3.4B+5.7%	$3.3B	N/A
Non-Current Liabilities	$5.9B+33.5%	$4.4B-0.3%	$4.5B-3.9%	$4.6B-19.1%	$5.7B-11.3%	$6.5B+11.2%	$5.8B-8.9%	$6.4B	N/A
Long-Term Debt	$4.0B+42.7%	$2.8B+3.8%	$2.7B-5.4%	$2.9B-20.3%	$3.6B-11.2%	$4.0B+25.3%	$3.2B-24.3%	$4.3B	N/A
Total Equity	$444.0M-58.7%	$1.1B-57.6%	$2.5B-24.1%	$3.3B-24.6%	$4.4B-20.7%	$5.6B+0.1%	$5.6B+11.6%	$5.0B-5.4%	$5.3B
Retained Earnings	$2.4B-30.4%	$3.5B-29.4%	$5.0B-3.1%	$5.1B-8.8%	$5.6B-10.3%	$6.3B-0.5%	$6.3B+24.4%	$5.1B	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$9.7B+9.6%	$9.9B+20.6%	$9.8B+17.4%	$10.1B+21.0%	$8.9B-6.5%	$8.2B-17.4%	$8.4B-16.4%	$8.3B-20.3%
Current Assets	$3.7B+4.3%	$3.8B+31.8%	$3.6B+21.6%	$3.8B+24.6%	$3.5B+16.1%	$2.9B-14.4%	$2.9B-7.6%	$3.0B-10.2%
Cash & Equivalents	$495.0M+10.2%	$585.0M+74.1%	$512.0M-11.1%	$479.0M-8.1%	$449.0M-7.4%	$336.0M-50.9%	$576.0M+11.0%	$521.0M-2.1%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$1.0B+19.7%	$1.0B+24.8%	$1.0B+46.2%	$1.1B+56.1%	$871.0M+18.2%	$836.0M+13.6%	$695.0M+5.1%	$732.0M+0.5%
Accounts Receivable	$1.2B+37.5%	$1.2B+48.7%	$1.1B+41.0%	$1.2B+45.7%	$862.0M+1.8%	$819.0M-3.2%	$796.0M-6.4%	$821.0M-6.7%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$2.2B+12.6%	$2.2B+12.6%	$2.2B+14.7%	$2.2B+27.7%	$2.0B-27.0%	$2.0B-28.2%	$1.9B-29.5%	$1.7B-37.1%
Total Liabilities	$9.2B+21.9%	$9.4B+35.3%	$9.2B+29.6%	$9.5B+39.5%	$7.5B+9.0%	$6.9B-5.6%	$7.1B-2.4%	$6.8B-8.5%
Current Liabilities	$3.1B+28.9%	$3.2B+21.3%	$3.2B+23.0%	$3.4B+42.0%	$2.4B+18.6%	$2.6B+8.2%	$2.6B-5.8%	$2.4B-20.4%
Non-Current Liabilities	$6.0B+18.6%	$6.2B+43.8%	$5.9B+33.5%	$6.1B+38.1%	$5.1B+5.0%	$4.3B-12.4%	$4.4B-0.3%	$4.4B-0.4%
Long-Term Debt	$4.2B+19.2%	$4.3B+58.6%	$4.0B+42.7%	$4.1B+47.2%	$3.5B+9.8%	$2.7B-15.6%	$2.8B+3.8%	$2.8B+0.5%
Total Equity	$323.0M-71.2%	$299.0M-71.6%	$444.0M-58.7%	$365.0M-72.0%	$1.1B-52.5%	$1.1B-55.7%	$1.1B-57.6%	$1.3B-53.3%
Retained Earnings	$2.3B-29.3%	$2.3B-31.8%	$2.4B-30.4%	$2.5B-29.3%	$3.3B-31.6%	$3.4B-29.5%	$3.5B-29.4%	$3.6B-29.6%

XRX Cash Flow Statement

XRX quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K
Operating Cash Flow	$217.0M	$224.0M-56.2%	$511.0M-25.5%	$686.0M+331.4%	$159.0M-74.7%	$629.0M+14.8%	$548.0M-58.9%	$1.3B+16.9%	$1.1B+527.0%	-$267.0M
Depreciation & Amortization	N/A	$331.0M+20.8%	$274.0M+9.2%	$251.0M-7.0%	$270.0M-17.4%	$327.0M-11.1%	$368.0M-14.4%	$430.0M-18.3%	$526.0M-0.2%	$527.0M
Stock-Based Compensation	N/A	$45.0M-13.5%	$52.0M-3.7%	$54.0M-28.0%	$75.0M+38.9%	$54.0M+28.6%	$42.0M-16.0%	$50.0M-12.3%	$57.0M+9.6%	$52.0M
Capital Expenditures	$54.0M	$37.0M+37.0%	$27.0M-6.9%	$29.0M-19.4%	$36.0M+24.1%	$29.0M-34.1%	$44.0M+7.3%	$41.0M-25.5%	$55.0M-20.3%	$69.0M
Free Cash Flow	$163.0M	$187.0M-61.4%	$484.0M-26.3%	$657.0M+434.1%	$123.0M-79.5%	$600.0M+19.0%	$504.0M-61.0%	$1.3B+19.1%	$1.1B+422.9%	-$336.0M
Investing Cash Flow	-$719.0M	-$698.0M-252.5%	-$198.0M-3860.0%	-$5.0M+93.6%	-$78.0M+8.2%	-$85.0M+65.4%	-$246.0M-111.5%	$2.1B+7506.9%	-$29.0M-117.6%	$165.0M
Financing Cash Flow	$73.0M	$404.0M+249.1%	-$271.0M+77.5%	-$1.2B-46.2%	-$822.0M+37.3%	-$1.3B-214.9%	-$416.0M+77.3%	-$1.8B-41.0%	-$1.3B-32.1%	-$985.0M
Dividends Paid	$29.0M	$71.0M-49.6%	$141.0M-14.5%	$165.0M-5.2%	$174.0M-15.5%	$206.0M-10.4%	$230.0M-5.3%	$243.0M-9.7%	$269.0M-7.6%	$291.0M
Share Buybacks	N/A	$0-100.0%	$8.0M-98.5%	$544.0M+381.4%	$113.0M-87.3%	$888.0M+196.0%	$300.0M-50.0%	$600.0M-14.3%	$700.0M	$0

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$37.0M+436.4%	-$144.0M-61.8%	$208.0M-40.7%	$116.0M0.0%	-$11.0M-108.9%	-$89.0M-12.7%	$351.0M-9.8%	$116.0M-6.5%
Depreciation & Amortization	$101.0M+77.2%	$100.0M+66.7%	$107.0M+10.3%	$107.0M+81.4%	$57.0M-3.4%	$60.0M+1.7%	$97.0M+56.5%	$59.0M-6.3%
Stock-Based Compensation	N/A	$9.0M-25.0%	N/A	N/A	N/A	$12.0M0.0%	N/A	N/A
Capital Expenditures	$14.0M+250.0%	$12.0M+140.0%	$16.0M+220.0%	$12.0M+50.0%	$4.0M-33.3%	$5.0M-37.5%	$5.0M-37.5%	$8.0M-20.0%
Free Cash Flow	$23.0M+253.3%	-$156.0M-66.0%	$192.0M-44.5%	$104.0M-3.7%	-$15.0M-112.8%	-$94.0M-8.0%	$346.0M-9.2%	$108.0M-5.3%
Investing Cash Flow	-$9.0M+50.0%	-$24.0M-500.0%	-$4.0M+97.7%	-$682.0M-9642.9%	-$18.0M-800.0%	$6.0M+135.3%	-$172.0M-2050.0%	-$7.0M-128.0%
Financing Cash Flow	-$114.0M-118.4%	$242.0M+252.2%	-$173.0M-41.8%	$118.0M+259.5%	$618.0M+283.9%	-$159.0M-160.9%	-$122.0M+68.1%	-$74.0M+21.3%
Dividends Paid	$6.0M-68.4%	$10.0M-74.4%	$6.0M-82.4%	$7.0M-80.6%	$19.0M-44.1%	$39.0M+5.4%	$34.0M0.0%	$36.0M-16.3%
Share Buybacks	N/A	N/A	$0-100.0%	$0	$0	$0-100.0%	$5.0M	$0-100.0%

XRX Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

XRX quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K
Gross Margin	N/A	N/A	N/A	3.9%-1.5pp	5.3%	N/A	N/A	N/A	N/A
Net Margin	-14.6%+6.6pp	-21.2%-21.2pp	0.0%+4.5pp	-4.5%+1.9pp	-6.5%-9.2pp	2.7%-12.2pp	14.9%+11.2pp	3.7%+1.8pp	1.9%
Return on Equity	-231.8%-109.0pp	-122.8%-122.8pp	0.0%+9.7pp	-9.6%+0.6pp	-10.3%-13.7pp	3.4%-20.8pp	24.2%+17.0pp	7.2%+3.5pp	3.7%
Return on Assets	-10.5%+5.3pp	-15.8%-15.8pp	0.0%+2.8pp	-2.8%+0.6pp	-3.4%-4.7pp	1.3%-7.7pp	9.0%+6.6pp	2.4%	N/A
Current Ratio	1.110.0x	1.120.0x	1.14-0.1x	1.23-0.4x	1.66-0.7x	2.33+0.5x	1.79+0.3x	1.45	N/A
Debt-to-Equity	9.04+6.4x	2.62+1.5x	1.07+0.2x	0.860.0x	0.81+0.1x	0.72+0.1x	0.58-0.3x	0.85	N/A
Asset Turnover	0.710.0x	0.74+0.1x	0.69+0.1x	0.62+0.1x	0.53+0.1x	0.48-0.1x	0.600.0x	0.65	N/A
FCF Margin	2.7%-5.1pp	7.8%-1.8pp	9.5%+7.8pp	1.7%-6.8pp	8.5%+1.3pp	7.2%-7.1pp	14.2%+3.0pp	11.2%+14.6pp	-3.4%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Gross Margin	10.6%+6.8pp	3.9%+2.4pp	N/A	N/A	3.7%	1.5%	N/A	N/A
Net Margin	0.7%+7.4pp	-5.7%+0.5pp	-3.6%-2.3pp	-38.8%+40.1pp	-6.7%-7.9pp	-6.2%+1.3pp	-1.3%+2.0pp	-78.9%-81.8pp
Return on Equity	4.0%+13.5pp	-35.1%-26.6pp	-16.4%-14.5pp	-208.2%-115.7pp	-9.4%-10.2pp	-8.6%-3.8pp	-2.0%+0.3pp	-92.5%-94.2pp
Return on Assets	0.1%+1.3pp	-1.1%0.0pp	-0.7%-0.5pp	-7.5%+6.9pp	-1.2%-1.4pp	-1.1%0.0pp	-0.3%+0.3pp	-14.5%-15.0pp
Current Ratio	1.18-0.3x	1.18+0.1x	1.110.0x	1.10-0.2x	1.460.0x	1.09-0.3x	1.120.0x	1.26+0.1x
Debt-to-Equity	12.86+9.8x	14.32+11.8x	9.04+6.4x	11.10+9.0x	3.11+1.8x	2.56+1.2x	2.62+1.5x	2.11+1.1x
Asset Turnover	0.200.0x	0.190.0x	0.210.0x	0.190.0x	0.180.0x	0.180.0x	0.190.0x	0.180.0x
FCF Margin	1.2%+2.1pp	-8.5%-2.0pp	9.5%-12.0pp	5.3%-1.8pp	-0.9%-8.4pp	-6.5%-0.7pp	21.4%-0.1pp	7.1%+0.2pp

Not reported in any period shown, so not listed: Operating Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Xerox Holdings Corporation XRX	FY2025	$7.0B	-$1.0B	-14.6%	$372.9M	19/100
Conduent Incorporated CNDT	FY2025	$3.0B	-$170.0M	-5.6%	$231.7M	21/100
TSS, Inc. TSSI	FY2025	$245.7M	$15.1M	6.2%	$260.2M	57/100
LZ Technology Holdings Limited LZMH	FY2025	$161.4M	-$24.8M	-15.4%	$9.4M	30/100
TechTarget, Inc. TTGT	FY2025	$486.8M	-$1.0B	N/A	$278.5M	36/100
Mercurity Fintech Holding Inc. MFH	FY2025	$1.9M	-$5.1M	N/A	$784.0M	67/100

Where Xerox Holdings Corporation Ranks

Frequently Asked Questions

What is Xerox Holdings Corporation's annual revenue?

Xerox Holdings Corporation (XRX) reported $7.0B in total revenue for fiscal year 2025. This represents a 12.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Xerox Holdings Corporation's revenue growing?

Xerox Holdings Corporation (XRX) revenue grew by 12.9% year-over-year, from $6.2B to $7.0B in fiscal year 2025.

Is Xerox Holdings Corporation profitable?

No, Xerox Holdings Corporation (XRX) reported a net income of -$1.0B in fiscal year 2025, with a net profit margin of -14.6%.

How much debt does Xerox Holdings Corporation have?

As of fiscal year 2025, Xerox Holdings Corporation (XRX) had $512.0M in cash and equivalents against $4.0B in long-term debt.

What is Xerox Holdings Corporation's net profit margin?

Xerox Holdings Corporation (XRX) had a net profit margin of -14.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Xerox Holdings Corporation pay dividends?

Yes, Xerox Holdings Corporation (XRX) paid $0.20 per share in dividends during fiscal year 2025.

What is Xerox Holdings Corporation's return on equity (ROE)?

Xerox Holdings Corporation (XRX) has a return on equity of -231.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Xerox Holdings Corporation's free cash flow?

Xerox Holdings Corporation (XRX) generated $187.0M in free cash flow during fiscal year 2025. This represents a -61.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Xerox Holdings Corporation's operating cash flow?

Xerox Holdings Corporation (XRX) generated $224.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Xerox Holdings Corporation's total assets?

Xerox Holdings Corporation (XRX) had $9.8B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Xerox Holdings Corporation's capital expenditures?

Xerox Holdings Corporation (XRX) invested $37.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How many shares does Xerox Holdings Corporation have outstanding?

Xerox Holdings Corporation (XRX) had 129M shares outstanding as of fiscal year 2025.

What is Xerox Holdings Corporation's current ratio?

Xerox Holdings Corporation (XRX) had a current ratio of 1.11 as of fiscal year 2025, which is considered adequate.

What is Xerox Holdings Corporation's debt-to-equity ratio?

Xerox Holdings Corporation (XRX) had a debt-to-equity ratio of 9.04 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Xerox Holdings Corporation's return on assets (ROA)?

Xerox Holdings Corporation (XRX) had a return on assets of -10.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Xerox Holdings Corporation's P/E ratio?

Xerox Holdings Corporation (XRX) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $372.9M as of Oct 13, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Xerox Holdings Corporation's price-to-sales ratio?

Xerox Holdings Corporation (XRX) trades at 0.0x sales, its market capitalization divided by revenue of $7.8B revenue, trailing 12 months to June 30, 2026. The market capitalization is $372.9M as of Oct 13, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Xerox Holdings Corporation's Piotroski F-Score?

Xerox Holdings Corporation (XRX) has a Piotroski F-Score of 3 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Xerox Holdings Corporation's earnings high quality?

Xerox Holdings Corporation (XRX) reported a net loss of $1.0B while generating $224.0M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Xerox Holdings Corporation?

Xerox Holdings Corporation (XRX) scores 19 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.